| INTRODUCTION
Exostosin-1 (EXT1) and Exostosin-2 (EXT2) genes encode Golgi-resident heparan sulfate (HS) glycosyltransferases involved in the synthesis of several HS-rich proteoglycan. 1 Since the 1990s, EXT1/EXT2 mutations have been identified in over 90% of cases of hereditary multiple exostoses (HME), an autosomal dominant inherited condition characterized by the early formation of cartilage-capped bone tumors (exostoses/ ostechondromas), typically located at the metaphyseal region of long bones or at the surface of flat bones (eg, scapula, hips, ribs). Here, we describe an Italian family affected by an intellectual disability syndrome with compound heterozygous missense mutations in the EXT2 gene identified by clinical exome sequencing. Clinical features of our family are similar in many respects to those of previously reported cases, 3, 4 aside for multiple exostoses present in our patients due to an EXT2 mutation inherited from the HME-affected mother.
This report adds evidence to further consider the AREXT2 as a distinct entity.
| PATIENTS AND METHODS
Written informed consent, approved by the Local Health Centre of Bari, and consent to publication were obtained from the family.
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The patients were born to Caucasian non-consanguineous parents. The father is in good health. Physical examination was normal, with no dysmorphic signs/palpable lesions/functional limitations.
Radiographic evaluation of the upper and lower limbs, pelvis, spine and chest excluded the presence of exostoses. He attended primary school and worked as a small farmer. The mother has HME. The same condition was present in her father and other relatives, consistent with dominant inheritance. Apart from the two affected siblings, she had two spontaneous abortions in the first-trimester.
| Case 1
The patient, a 21-year-old male, is the first of two siblings. Apgar score at birth was 7/8 and weight 2850 g (25th centile). He had persistent patent ductus arteriosus (PDA), surgically closed at the age of 
| Case 2
The patient is the youngest sister of the proband, born in 2003 after an uneventful pregnancy. Birth weight was 3050 g (50th centile). She presented neonatal apnea, which resolved spontaneously. MRI showed a mild enlargement of the subarachnoid spaces.
Echocardiography showed PDA with mild pulmonary stenosis that was surgically closed. At 2 years of age febrile and, successively, afebrile seizures appeared. Antiepileptic treatment with carbamazepin and topiramate was started without clinical response. Last EEG examination at 13 years of age detected a disorganized electrical activity with diffuse spike-and-wave discharges. Valproic acid therapy was administered with a better, but incomplete, control of crisis.
At last examination, her weight was 49 kg (25th-50th percentile), Psychomotor development was delayed, especially regarding language skills. She walked unaided at 2 years of age, but still has unsteady gait and struggles with coordination. She attends regular school with special education assistance (one-to-one support) but has more interaction skills than her brother, and does not show any repetitive and/or obsessive behavior.
| Genetic studies
See Supporting Information (Appendix S1).
| RESULTS
Targeted exome sequencing data analysis (Supporting Information Figure 2B-D) . Unfortunately, the molecular modeling of the p.
Asp227Asn variant is not available because, up to date, the structure of the exostosin domain is still unknown.
| DISCUSSION
Here, we describe an Italian family with two siblings affected by a developmental disorder characterized by severe intellectual disability, seizures, skeletal abnormalities, multiple exostoses and dysmorphisms.
Exome sequencing revealed that the affected subjects were compound heterozygous for two missense variants in EXT2 gene, p.
Asp227Asn, and p.Tyr608Cys.
Currently, only two other families with a similar EXT2-related syndrome have been reported (Table 1) scoliosis were present in their patients. In our cases, we observed a further phenotypic variability (Table 1) ; therefore, the new acronym AREXT2 seems to be more appropriate.
EXT2 gene belongs to the EXT gene family, which is involved in the synthesis of HS. EXT1 and EXT2 are ubiquitously expressed transmembrane proteins, with one transmembrane region and two critical domains: the "exostosin" domain and the "glycosyltransferase family 64" domain. EXT1/EXT2 mutations are associated with the formation of exostoses, also known as osteochondromas, which are benign cartilage-capped bone tumors that occur in HME patients or as part of the Langer-Giedion/Potocki-Shaffer microdeletion syndromes. 2 As reviewed by Pacifici, 7 it seems that EXT1/EXT2 mutations lead to reduced production of HS, disrupting the Bone Morphogenetic Protein (BMP) and other HS-binding growth factor-signaling pathways involved in chondrogenesis. However, a partial decrease in EXT2 expression is tolerated and an additional somatic genetic event is probably required for the formation of ostechondromas, according to the "two-hit" hypothesis. 7, 8 The main difference between our patients and those previously reported is the presence of exostoses. 4 Both these families were consanguineous, and the patients were homozygous for EXT2 missense variants, located at the N-terminal, outside the EXT2 protein functional domains. In our family exostoses are present, located at the long bones in the patients as well in the mother, and other members of her family, with the EXT2 variant p.Asp260Asn, localized in the exostosin domain. Therefore, the presence/absence of the exostoses might be dependent on the position of the EXT2 variants inside/outside the exostosin domain, whose impairment may have drastic consequences for the protein's function. This hypothesis seems to be corroborated by the observation that the few EXT1 and EXT2 missense variants, identified in HME patients, usually fall into the exostosin domain.
2,9
The other EXT2 missense change, p.Tyr608Cys, falls in the Cterminal glycosyltransferase domain and was inherited from the father who has not exostoses. Tyr608, studied by homology modeling, turns out to be involved in multiple interactions with surrounding residues determining the fold of the glycosyltransferase domain nearby the catalytic region ( Figure 2D ). The replacing tiny cysteine cannot reproduce the same interactions as the aromatic tyrosine in the wild-type protein, thus we expect loss of the structural integrity and impaired activity of the glycosyltransferase domain of EXT2. Therefore, this variant could reduce the EXT2 activity sufficiently to cause, in association with the other amino acid change, the AREXT2 syndrome in our Intellectual disability of AREXT2 patients could be explained considering the phenotype of EXT1-knockout mice targeted to postnatal neurons. 11 These conditional EXT1 mutant mice show an autism-like behavior without any detectable morphological changes in the brain.
Electrophysiological analyses indicate that removal of HS compromises glutamatergic synaptic transmission. 11 Seizures is a relevant clinical feature in the AREXT2 syndrome, and it is observed in all patients, usually severe and with an early onset. Epilepsy was less severe in our patients, which showed a good response to valproate therapy. Susceptibility to epilepsy could be due to the impairment of the homeostatic regulation at the GABAergic synapses with loss of the inhibitory upregulation in response to a prolonged neuronal activity. 12 Interestingly, our patients responded to the antiepileptic treatment with valproate, which works by increasing GABA levels in the brain.
To conclude, we report on a third family with AREXT2 syndrome, for the first time with no consanguinity and harboring EXT2 compound heterozygous variants. Our report expands the phenotypic and mutational spectrum of this disorder, showing a possible genotype/ phenotype correlation in the development of the exostoses that can have an impact on clinical management of patients with AREXT2
syndrome.
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